Evidence for the regulation of L-type Ca2+ channels in the heart by reactive oxygen species: Mechanism for mediating pathology

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 2, 2008, Pages 229-234

  Hool, Livia C ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cysteines; Ion channels; Mitochondria; Reactive oxygen species; Redox

Indexed keywords

ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CYSTEINE DERIVATIVE; DITHIOTHREITOL; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE; VERAPAMIL;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL FUNCTION; CONFERENCE PAPER; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPOXIA; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS;

ANIMALS; ANOXIA; ANTIOXIDANTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CYSTEINE; HEART DISEASES; HUMANS; ION CHANNEL GATING; MYOCARDIUM; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 38149077988     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04727.x     Document Type: Conference Paper

References (59)

1. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 1993 23: 118 26.
2. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 2000 279: L1005 28.
3. Salmeen A, Andersen JN, Myers MP et al. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 2003 423: 769 73.
4. van Montfort RL, Congreve M, Tisi D, Carr R, Jhoti H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 2003 423: 773 7.
5. Stone JR, Yang S. Hydrogen peroxide: A signaling messenger. Antioxid. Redox Signal. 2006 8: 243 70.
6. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler. Thromb. Vasc. Biol. 2000 20: 1430 42.
7. Sabri A, Hughie HH, Lucchesi PA. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid. Redox Signal. 2003 5: 731 40.
8. Nakagami H, Takemoto M, Liao JK. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 2003 35: 851 9.
9. Bolli R. Causative role of oxyradicals in myocardial stunning: A proven hypothesis. A brief review of the evidence demonstrating a major role of reactive oxygen species in several forms of postischemic dysfunction. Basic Res. Cardiol. 1998 93: 156 62.
10. Molkentin JD, Lu JR, Antos CL et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998 93: 215 28.
11. Ruwhof C, van der Laarse A. Mechanical stress-induced cardiac hypertrophy: Mechanisms and signal transduction pathways. Cardiovasc. Res. 2000 47: 23 37.
12. 2+ channel: Perspectives for new pharmacological targets. J. Pharmacol. Exp. Ther. 2002 300: 724 8.
13. Campbell DL, Stamler JS, Strauss HC. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J. Gen. Physiol. 1996 108: 277 93.
14. Lipton SA, Choi YB, Pan ZH et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993 364: 626 32.
15. Gilbert HF. Molecular and cellular aspects of thiol-disulfide exchange. Adv. Enzymol. Relat. Areas Mol. Biol. 1990 63: 69 172.
16. + channels. Circ. Res. 1995 76: 325 34.
17. 2+ current to β-adrenergic receptor stimulation via a C2 region-containing protein kinase C isoform. Circ. Res. 2000 87: 1164 71.
18. 2+ channel to α-adrenergic receptor stimulation in the presence of β-adrenergic receptor stimulation. Circ. Res. 2001 88: 1036 43.
19. 1C subunits by redox agents and hypoxia. J. Physiol. 1999 514: 629 37.
20. Lacampagne A, Duittoz A, Bolanos P, Peineau N, Argibay JA. Effect of sulfhydryl oxidation on ionic and gating currents associated with L-type calcium channels in isolated guinea-pig ventricular myocytes. Cardiovasc. Res. 1995 30: 799 806.
21. 2+ channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors. J. Neurosci. 2005 25: 8766 75.
22. Todorovic SM, Jevtovic-Todorovic V, Meyenburg A et al. Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron 2001 31: 75 85.
23. 2+ channel in frog ventricular myocytes. Pflügers Arch. 2000 440: 207 15.
24. Zeng XH, Xia XM, Lingle CJ. Redox-sensitive extracellular gates formed by auxiliary β subunits of calcium-activated potassium channels. Nat. Struct. Biol. 2003 10: 448 54.
25. Jeroudi MO, Hartley CJ, Bolli R. Myocardial reperfusion injury: Role of oxygen radicals and potential therapy with antioxidants. Am. J. Cardiol. 1994 73: B2 7.
26. Sanguinetti MC. When the KChIPs are down. Nat. Med. 2002 8: 18 19.
27. Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 2001 104: 569 80.
28. Aon MA, Cortassa S, Marban E, O'Rourke B. Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J. Biol. Chem. 2003 278: 44 735 44.
29. Akar FG, Aon MA, Tomaselli GF, O'Rourke B. The mitochondrial origin of postischemic arrhythmias. J. Clin. Invest. 2005 115: 3527 35.
30. 2+ channels on early after-depolarizations. Biophys. J. 2005 88: 85 95.
31. 2+ channel activity by hypoxia in human and porcine coronary myocytes. Cardiovasc. Res. 2002 53: 97 104.
32. 2+ channel to beta-adrenergic receptor stimulation in cardiac myocytes. Circ. Res. 2002 91: 601 9.
33. 2+ channel function during acute hypoxia. Cardiovasc. Res. 2005 67: 624 35.
34. 2+ channel. J. Physiol. 1997 500: 551 6.
35. 2+ channels. Circ. Res. 2000 87: 537 9.
36. + channels in smooth muscle cells by a mitochondrial redox sensor. Circ. Res. 2002 91: 478 86.
37. Weir EK, Archer SL. The mechanism of acute hypoxic pulmonary vasoconstriction: The tale of two channels. FASEB J. 1995 9: 183 9.
38. Weir EK, Hong Z, Porter VA, Reeve HL. Redox signaling in oxygen sensing by vessels. Respir. Physiol. Neurobiol. 2002 132: 121 30.
39. 2 sensor. J. Biol. Chem. 1998 273: 3320 6.
40. Waypa GB, Guzy R, Mungai PT et al. Increases in mitochondrial reactive oxygen species trigger hypoxia-induced calcium responses in pulmonary artery smooth muscle cells. Circ. Res. 2006 99: 970 8.
41. Ganitkevich V, Reil S, Schwethelm B, Schroeter T, Benndorf K. Dynamic responses of single cardiomyocytes to graded ischemia studied by oxygen clamp in on-chip picochambers. Circ. Res. 2006 99: 165 71.
42. Carmeliet E. Cardiac ionic currents and acute ischemia: From channels to arrhythmias. Physiol. Rev. 1999 79: 917 1017.
43. McDonald TF, Pelzer S, Trautwein W, Pelzer DJ. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol. Rev. 1994 74: 365 507.
44. 2+ channel activity by phenylarsine oxide. Br. J. Pharmacol. 2004 142: 797 807.
45. Humphries KM, Juliano C, Taylor SS. Regulation of cAMP-dependent protein kinase activity by glutathionylation. J. Biol. Chem. 2002 277: 43 505 11.
46. Humphries KM, Deal MS, Taylor SS. Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification. J. Biol. Chem. 2005 280: 2750 8.
47. Brennan JP, Bardswell SC, Burgoyne JR et al. Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. J. Biol. Chem. 2006 281: 21 827 36.
48. 1C subunits but does not mediate their sensitivity to acute hypoxia. Biochem. Biophys. Res. Commun. 2004 318: 135 41.
49. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: A mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 2004 287: C817 33.
50. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 2000 192: 1001 14.
51. 2+ in left ventricular myocyte sub-types from rabbits with heart failure. Cardiovasc. Res. 2000 45: 397 409.
52. 2+ channel function in the absence of apoptosis in ventricular myocytes. Circ. Res. 2007 100: 1036 44.
53. Napoli C, Sica V, Pignalosa O, de Nigris F. New trends in anti-atherosclerotic agents. Curr. Med. Chem. 2005 12: 1755 72.
54. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Cayatte AJ, Mowery J. Atherosclerosis. Potential targets for stabilization and regression. Circulation 1992 86 (Sup pl III 117 23.
55. Pizzetti G, Mailhac A, Li Volsi L et al. Beneficial effects of diltiazem during myocardial reperfusion: A randomized trial in acute myocardial infarction. Ital. Heart J. 2001 2: 757 65.
56. Bestehorn HP, Neumann FJ, Buttner HJ et al. Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: The randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial. J. Am. Coll. Cardiol. 2004 43: 2160 5.
57. Umemoto S, Tanaka M, Kawahara S et al. Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats. Hypertens. Res. 2004 27: 877 85.
58. Wang QD, Pernow J, Sjoquist PO, Ryden L. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc. Res. 2002 55: 25 37.
59. Kloner RA, Jennings RB. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part 1. Circulation 2001 104: 2981 9.